http://www.noxopharm.com/irm/PDF/16...eportpreparedbyEverBluCapitalResearchJuly2018
We are initiating coverage on NOX with a 12-month price target of $1.50/sh and a SPECULATIVE BUY recommendation.
I am pleased to see in the report that the author plus the directors of EverBluCapital own shares in Noxopharm. The report may have been commissioned by Noxopharm, but it is nice to see that EverBlue principals strongly believe in the potential of the company.
July 18 Research Report
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 10.0¢ | $6.181K | 58.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 42445 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 14000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
